Teva Tries To Nix Investors' 'Defective' Price-Hike Suit
Teva Pharmaceutical Industries Ltd. and its executives doubled down on their efforts to toss securities claims from investors, who say the drugmaker engaged in a price-hike scheme and misled them about...To view the full article, register now.
Already a subscriber? Click here to view full article